Uniqsis Reports on Expansion
Uniqsis (Shepreth, UK), a market leader in flow chemistry, reports following excellent business growth in 2017 that it has recruited a further sales / support specialist to be located at its office in Cambridge.
Paul Pergande, Managing Director of Uniqsis commented "We are very pleased to welcome Steve Evans to Uniqsis. Steve's strong technical background as well as his in-depth knowledge of continuous flow reactor equipment and applications will be a major asset to both Uniqsis and its customers worldwide".
Steve Evans said “I am delighted to have joined Uniqsis and am very much looking forward to contributing to the continued success and growth of the company as we move into the next phase of its development”.
During 2017, Uniqsis achieved double-digit growth in North America and Europe with a notable increase in sales of its high performance FlowSyn integrated continuous flow reactor systems for pharmaceutical, nanomaterials and academic research applications.
Reflecting upon technical developments in 2017, Dr Mark Ladlow (Chief Scientific Officer) commented “Our ability to develop unique new products such as our entry-level Flowlab range of modular flow reactor systems, Flow-UV™ in-line UV-Vis detector and offer custom FlowSyn systems has enabled us to provide optimised application solutions for end users in a growing number of end user markets. He added “Investment made possible by our success last year will enable Uniqsis to bring several further new products to market in 2018”.
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
This Seed Could Bring Clean Water to MillionsNews
Biomedical Engineering and Chemical Engineering Professors Bob Tilton and Todd Przybycien recently co-authored a paper with Ph.D. students Brittany Nordmark and Toni Bechtel, and alumnus John Riley, further refining a process that could soon help provide clean water to many in water-scarce regions. The process, created by Tilton’s former student and co-author Stephanie Velegol, uses sand and plant materials readily available in many developing nations to create a cheap and effective water filtration medium, termed “f-sand.”READ MORE
Combining Different Malaria Vaccines Could Reduce Cases by 91%News
Using two experimental anti-malarial vaccines, which work in different ways, can greatly reduce the number of malaria infections in animal studies. Experimental vaccines, which independently achieve 48% and 68% reductions in malaria cases, can achieve 91% reduction when combined.